Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

Joaquin J Jimenez, Wenche Jy, Lucia M. Mauro, Lawrence L. Horstman, Carl Soderland, Yeon Ahn

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

It has been suggested that endothelial apoptosis is a primary lesion in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). We tested this hypothesis by examining the phenotypic signatures of endothelial microparticles (EMP) in TTP patients. In addition, the effect of TTP plasma on microvascular endothelial cells (MVEC) in culture was further delineated. EMP released by endothelial cells (EC) express markers of the parent EC; EMP released in activation carry predominantly CD54 and CD62E, while those in apoptosis CD31 and CD105. We investigated EMP release in vitro and in TTP patients. Following incubation of MVEC with TTP plasma, EMP and EC were analysed by flow cytometry for the expression of CD31, CD51, CDS4, CD62E, CD105, CD106 and von Willebrand factor (VWF) antigen. EMP were also analysed in 12 TTP patients. In both EC and EMP, CD62E and CD54 expression were increased 3- to 10-fold and 8- to 10-fold respectively. However, CD31 and CD105 were reduced 40-60% in EC but increased twofold in EMP. VWF expression was found in 55 ± 15% of CD62E + EMP. Markers of apoptosis were negative. In TTP patients, CD62E+ and CD31+/CD42b- EMP were markedly elevated, and preceded and correlated well with a rise in platelet counts and a fall in lactate dehydrogenase. CD62E+ EMP (60 ± 20%) co-expressed VWF and CD62E. The ratio of CD31+/42b- to CD62E+ EMP exhibited a pattern consistent with activation. In conclusion, our studies indicate endothelial activation in TTP, EMP that co-express VWF and CD62E could play a role in the pathogenesis of TTP.

Original languageEnglish
Pages (from-to)896-902
Number of pages7
JournalBritish Journal of Haematology
Volume123
Issue number5
DOIs
StatePublished - Dec 1 2003

Fingerprint

Thrombotic Thrombocytopenic Purpura
von Willebrand Factor
Endothelial Cells
Apoptosis
Platelet Count
L-Lactate Dehydrogenase
Flow Cytometry
Cell Culture Techniques

Keywords

  • Endothelial cell activation
  • Endothelial microparticles
  • Endothelium
  • Thrombotic thrombocytopenic purpura
  • Von Willebrand factor

ASJC Scopus subject areas

  • Hematology

Cite this

Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. / Jimenez, Joaquin J; Jy, Wenche; Mauro, Lucia M.; Horstman, Lawrence L.; Soderland, Carl; Ahn, Yeon.

In: British Journal of Haematology, Vol. 123, No. 5, 01.12.2003, p. 896-902.

Research output: Contribution to journalArticle

@article{b2d52a87ced445a1b6210041050bc598,
title = "Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation",
abstract = "It has been suggested that endothelial apoptosis is a primary lesion in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). We tested this hypothesis by examining the phenotypic signatures of endothelial microparticles (EMP) in TTP patients. In addition, the effect of TTP plasma on microvascular endothelial cells (MVEC) in culture was further delineated. EMP released by endothelial cells (EC) express markers of the parent EC; EMP released in activation carry predominantly CD54 and CD62E, while those in apoptosis CD31 and CD105. We investigated EMP release in vitro and in TTP patients. Following incubation of MVEC with TTP plasma, EMP and EC were analysed by flow cytometry for the expression of CD31, CD51, CDS4, CD62E, CD105, CD106 and von Willebrand factor (VWF) antigen. EMP were also analysed in 12 TTP patients. In both EC and EMP, CD62E and CD54 expression were increased 3- to 10-fold and 8- to 10-fold respectively. However, CD31 and CD105 were reduced 40-60{\%} in EC but increased twofold in EMP. VWF expression was found in 55 ± 15{\%} of CD62E + EMP. Markers of apoptosis were negative. In TTP patients, CD62E+ and CD31+/CD42b- EMP were markedly elevated, and preceded and correlated well with a rise in platelet counts and a fall in lactate dehydrogenase. CD62E+ EMP (60 ± 20{\%}) co-expressed VWF and CD62E. The ratio of CD31+/42b- to CD62E+ EMP exhibited a pattern consistent with activation. In conclusion, our studies indicate endothelial activation in TTP, EMP that co-express VWF and CD62E could play a role in the pathogenesis of TTP.",
keywords = "Endothelial cell activation, Endothelial microparticles, Endothelium, Thrombotic thrombocytopenic purpura, Von Willebrand factor",
author = "Jimenez, {Joaquin J} and Wenche Jy and Mauro, {Lucia M.} and Horstman, {Lawrence L.} and Carl Soderland and Yeon Ahn",
year = "2003",
month = "12",
day = "1",
doi = "10.1046/j.1365-2141.2003.04716.x",
language = "English",
volume = "123",
pages = "896--902",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

AU - Jimenez, Joaquin J

AU - Jy, Wenche

AU - Mauro, Lucia M.

AU - Horstman, Lawrence L.

AU - Soderland, Carl

AU - Ahn, Yeon

PY - 2003/12/1

Y1 - 2003/12/1

N2 - It has been suggested that endothelial apoptosis is a primary lesion in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). We tested this hypothesis by examining the phenotypic signatures of endothelial microparticles (EMP) in TTP patients. In addition, the effect of TTP plasma on microvascular endothelial cells (MVEC) in culture was further delineated. EMP released by endothelial cells (EC) express markers of the parent EC; EMP released in activation carry predominantly CD54 and CD62E, while those in apoptosis CD31 and CD105. We investigated EMP release in vitro and in TTP patients. Following incubation of MVEC with TTP plasma, EMP and EC were analysed by flow cytometry for the expression of CD31, CD51, CDS4, CD62E, CD105, CD106 and von Willebrand factor (VWF) antigen. EMP were also analysed in 12 TTP patients. In both EC and EMP, CD62E and CD54 expression were increased 3- to 10-fold and 8- to 10-fold respectively. However, CD31 and CD105 were reduced 40-60% in EC but increased twofold in EMP. VWF expression was found in 55 ± 15% of CD62E + EMP. Markers of apoptosis were negative. In TTP patients, CD62E+ and CD31+/CD42b- EMP were markedly elevated, and preceded and correlated well with a rise in platelet counts and a fall in lactate dehydrogenase. CD62E+ EMP (60 ± 20%) co-expressed VWF and CD62E. The ratio of CD31+/42b- to CD62E+ EMP exhibited a pattern consistent with activation. In conclusion, our studies indicate endothelial activation in TTP, EMP that co-express VWF and CD62E could play a role in the pathogenesis of TTP.

AB - It has been suggested that endothelial apoptosis is a primary lesion in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). We tested this hypothesis by examining the phenotypic signatures of endothelial microparticles (EMP) in TTP patients. In addition, the effect of TTP plasma on microvascular endothelial cells (MVEC) in culture was further delineated. EMP released by endothelial cells (EC) express markers of the parent EC; EMP released in activation carry predominantly CD54 and CD62E, while those in apoptosis CD31 and CD105. We investigated EMP release in vitro and in TTP patients. Following incubation of MVEC with TTP plasma, EMP and EC were analysed by flow cytometry for the expression of CD31, CD51, CDS4, CD62E, CD105, CD106 and von Willebrand factor (VWF) antigen. EMP were also analysed in 12 TTP patients. In both EC and EMP, CD62E and CD54 expression were increased 3- to 10-fold and 8- to 10-fold respectively. However, CD31 and CD105 were reduced 40-60% in EC but increased twofold in EMP. VWF expression was found in 55 ± 15% of CD62E + EMP. Markers of apoptosis were negative. In TTP patients, CD62E+ and CD31+/CD42b- EMP were markedly elevated, and preceded and correlated well with a rise in platelet counts and a fall in lactate dehydrogenase. CD62E+ EMP (60 ± 20%) co-expressed VWF and CD62E. The ratio of CD31+/42b- to CD62E+ EMP exhibited a pattern consistent with activation. In conclusion, our studies indicate endothelial activation in TTP, EMP that co-express VWF and CD62E could play a role in the pathogenesis of TTP.

KW - Endothelial cell activation

KW - Endothelial microparticles

KW - Endothelium

KW - Thrombotic thrombocytopenic purpura

KW - Von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=0346219274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346219274&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2003.04716.x

DO - 10.1046/j.1365-2141.2003.04716.x

M3 - Article

C2 - 14632781

AN - SCOPUS:0346219274

VL - 123

SP - 896

EP - 902

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -